Faes Farma Toekomstige groei
Future criteriumcontroles 3/6
Faes Farma zal naar verwachting groeien in winst en omzet met respectievelijk 16% en 7.3% per jaar. De winst per aandeel zal naar verwachting groeien met 15.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 14.4% zijn.
Belangrijke informatie
16.0%
Groei van de winst
15.88%
Groei van de winst per aandeel
| Pharmaceuticals winstgroei | 17.4% |
| Inkomstengroei | 7.3% |
| Toekomstig rendement op eigen vermogen | 14.43% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 31 Jul 2026 |
Recente toekomstige groei-updates
Recent updates
Latin American Expansion And Ophthalmology Integration Will Reshape This Pharma Group’s Future Profile
Catalysts About Faes Farma Faes Farma is a pharmaceutical and animal nutrition group with a growing international footprint, including Iberia, Latin America and ophthalmology operations through SIFI and Edol. What are the underlying business or industry changes driving this perspective?Here's Why We Think Faes Farma (BME:FAE) Might Deserve Your Attention Today
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Improved Earnings Required Before Faes Farma, S.A. (BME:FAE) Shares Find Their Feet
When close to half the companies in Spain have price-to-earnings ratios (or "P/E's") above 18x, you may consider Faes...Does Faes Farma (BME:FAE) Deserve A Spot On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0332
Faes Farma, S.A. ( BME:FAE ) will pay a dividend of €0.0332 on the 13th of January. This makes the dividend yield 4.5...Faes Farma's (BME:FAE) Dividend Will Be €0.0332
The board of Faes Farma, S.A. ( BME:FAE ) has announced that it will pay a dividend on the 13th of January, with...Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
As you might know, Faes Farma, S.A. ( BME:FAE ) recently reported its third-quarter numbers. It was an okay result...Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think
Faes Farma, S.A. ( BME:FAE ) came out with its annual results last week, and we wanted to see how the business is...Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316
The board of Faes Farma, S.A. ( BME:FAE ) has announced that it will pay a dividend of €0.0316 per share on the 15th of...Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316
The board of Faes Farma, S.A. ( BME:FAE ) has announced that it will pay a dividend of €0.0316 per share on the 15th of...Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?
Does the September share price for Faes Farma, S.A. ( BME:FAE ) reflect what it's really worth? Today, we will estimate...Is Faes Farma (BME:FAE) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Is Faes Farma (BME:FAE) Using Too Much Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14
The board of Faes Farma, S.A. ( BME:FAE ) has announced that it will be increasing its dividend on the 23rd of December...Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17
Faes Farma, S.A. ( BME:FAE ) will increase its dividend on the 23rd of December to €0.17. This takes the dividend yield...Is Faes Farma (BME:FAE) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year
Last week saw the newest half-yearly earnings release from Faes Farma, S.A. ( BME:FAE ), an important milestone in the...Is Faes Farma (BME:FAE) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)
Does the April share price for Faes Farma, S.A. ( BME:FAE ) reflect what it's really worth? Today, we will estimate the...Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?
Today we'll take a closer look at Faes Farma, S.A. ( BME:FAE ) from a dividend investor's perspective. Owning a strong...Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations
Faes Farma, S.A.'s ( BME:FAE ) healthy profit numbers didn't contain any surprises for investors. We think this is due...Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment
When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses is...I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2028 | 853 | 126 | 105 | 142 | 3 |
| 12/31/2027 | 793 | 111 | 97 | 130 | 4 |
| 12/31/2026 | 733 | 87 | 77 | 120 | 4 |
| 6/30/2026 | 711 | 84 | 55 | 80 | N/A |
| 3/31/2026 | 674 | 82 | N/A | N/A | N/A |
| 12/31/2025 | 627 | 80 | 55 | 78 | N/A |
| 9/30/2025 | 571 | 105 | N/A | N/A | N/A |
| 6/30/2025 | 544 | 105 | 73 | 101 | N/A |
| 3/31/2025 | 524 | 109 | N/A | N/A | N/A |
| 12/31/2024 | 510 | 111 | 76 | 115 | N/A |
| 9/30/2024 | 504 | 98 | N/A | N/A | N/A |
| 6/30/2024 | 494 | 97 | 44 | 106 | N/A |
| 3/31/2024 | 482 | 95 | N/A | N/A | N/A |
| 12/31/2023 | 473 | 92 | -1 | 101 | N/A |
| 9/30/2023 | 472 | 90 | N/A | N/A | N/A |
| 6/30/2023 | 469 | 90 | -9 | 98 | N/A |
| 3/31/2023 | 467 | 91 | N/A | N/A | N/A |
| 12/31/2022 | 462 | 89 | 26 | 107 | N/A |
| 9/30/2022 | 460 | 86 | N/A | N/A | N/A |
| 6/30/2022 | 466 | 88 | 50 | 113 | N/A |
| 3/31/2022 | 449 | 88 | N/A | N/A | N/A |
| 12/31/2021 | 429 | 82 | 20 | 80 | N/A |
| 9/30/2021 | 416 | 81 | N/A | N/A | N/A |
| 6/30/2021 | 398 | 74 | 8 | 56 | N/A |
| 3/31/2021 | 394 | 73 | N/A | N/A | N/A |
| 12/31/2020 | 411 | 73 | 53 | 78 | N/A |
| 9/30/2020 | 408 | 77 | N/A | N/A | N/A |
| 6/30/2020 | 407 | 73 | 57 | 78 | N/A |
| 3/31/2020 | 409 | 68 | N/A | N/A | N/A |
| 12/31/2019 | 383 | 64 | N/A | 68 | N/A |
| 9/30/2019 | 379 | 60 | N/A | N/A | N/A |
| 6/30/2019 | 363 | 59 | N/A | 74 | N/A |
| 3/31/2019 | 351 | 54 | N/A | N/A | N/A |
| 12/31/2018 | 340 | 52 | N/A | 59 | N/A |
| 9/30/2018 | 334 | 51 | N/A | N/A | N/A |
| 6/30/2018 | 330 | 49 | N/A | 58 | N/A |
| 3/31/2018 | 308 | 47 | N/A | N/A | N/A |
| 12/31/2017 | 282 | 41 | N/A | 42 | N/A |
| 9/30/2017 | 266 | 39 | N/A | N/A | N/A |
| 6/30/2017 | 250 | 39 | N/A | 43 | N/A |
| 3/31/2017 | 241 | 38 | N/A | N/A | N/A |
| 12/31/2016 | 237 | 37 | N/A | 50 | N/A |
| 9/30/2016 | 226 | 35 | N/A | N/A | N/A |
| 6/30/2016 | 222 | 34 | N/A | 40 | N/A |
| 3/31/2016 | 220 | 32 | N/A | N/A | N/A |
| 12/31/2015 | 214 | 30 | N/A | 41 | N/A |
| 9/30/2015 | 207 | 28 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei FAE ( 16% per jaar) ligt boven de spaarquote ( 2.9% ).
Winst versus markt: De winst van FAE ( 16% per jaar) zal naar verwachting sneller groeien dan de Spanish markt ( 11.4% per jaar).
Hoge groeiwinsten: De winst van FAE zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van FAE ( 7.3% per jaar) zal naar verwachting sneller groeien dan de markt Spanish ( 6.4% per jaar).
Hoge groei-inkomsten: De omzet van FAE ( 7.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen FAE zal naar verwachting over 3 jaar laag zijn ( 14.4 %).
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/13 22:05 |
| Aandelenkoers aan het einde van de dag | 2026/09/11 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Faes Farma, S.A. wordt gevolgd door 9 analisten. 4 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Javier Esteban Lario | Banco de Sabadell. S.A. |
| Jesús Gómez Dominguez | Banco Santander |
| José Romero Herrero | Banco Santander |